Source: BEFREE
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1986 | 1986 | ||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1989 | 2019 | |||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.100 | None | 0.942 | 69 | 0 | 1992 | 2019 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 1992 | 2009 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.975 | 159 | 0 | 1993 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.917 | 12 | 0 | 1993 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.480 | None | 1.000 | 8 | 0 | 1994 | 2015 | ||||||||
|
hypoxanthine phosphoribosyltransferase 1 | 0.500 | 0.808 | 0.94 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
calcitonin related polypeptide alpha | 0.416 | 0.923 | 1.6E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
disease | 0.500 | None | 0.979 | 91 | 4 | 1995 | 2020 | ||||||||
|
thrombopoietin | 0.513 | 0.692 | 0.20 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1995 | 2020 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2018 | ||||||||
|
KIT ligand | 0.473 | 0.885 | 0.85 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2010 | ||||||||
|
Leukemia, acute lymphocytic, susceptibility to, 1 | 0.636 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | |||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1996 | 2004 | ||||||||
|
RAS p21 protein activator 1 | 0.481 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
ERCC excision repair 8, CSA ubiquitin ligase complex subunit | 0.551 | 0.885 | 2.8E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
chorionic somatomammotropin hormone 1 | 0.566 | 0.808 | 2.1E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
chorionic somatomammotropin hormone 2 | 0.566 | 0.808 | 1.3E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
heat shock protein family A (Hsp70) member 9 | 0.502 | 0.885 | 0.97 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
erythropoietin | 0.381 | 0.885 | 1.1E-02 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1997 | 2018 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1997 | 2018 | ||||||||
|
MDS1 and EVI1 complex locus | 0.513 | 0.731 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 1997 | 2018 | ||||||||
|
retinoic acid receptor alpha | 0.470 | 0.846 | 0.96 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 |